Skip to main content
Erschienen in: Updates in Surgery 4/2020

09.05.2020 | Original Article

The impact of negative lymph nodes in the survival outcomes of pN+ patients following radical gastrectomy: the inverse lymph node ratio as a better score to study negative lymph nodes

verfasst von: Paulo Matos da Costa, Patrícia Lages, Susana Onofre, Ruy M. Ribeiro

Erschienen in: Updates in Surgery | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

The impact of negative lymph nodes (LNs) on survival of pN+ patients has been recognized. The weight of negative LNs in an inverse lymph node ratio (nR) should be related to its prognostic impact. Five hundred and two consecutive gastric cancer patients, who underwent radical gastrectomy, were included. Patients were split into groups according to the number of harvested nodes and a cross-tabulation with pTNM stages was performed to test differences in the tumor burden. pN+ patients (n = 296) were split into groups of negative LNs harvested. We tested an alternative formula for computing a lymph node ratio: nR = total number of harvested nodes/total number of positive nodes. The median number of negative LNs was significantly different (p < 0.01) between dissection groups, but not the median of positive nodes (p > 0.05). No difference in pTNM percentage distribution was found between these groups (p > 0.05). When tested, the overall survival improved significantly for groups with larger numbers of negative LNs (p < 0.001). A cutoff of nR ≥ 6 was an independent prognostic factor for survival (p = 0.001), and the survival of pN+ patients with nR ≥ 6 was not different from pN0 patients. The impact of the number of negative LNs on the survival of the pN+ patients was demonstrated. The higher numbers in the numerator of the nR was due to the disproportion between harvested negative LNs and metastatic LNs. Larger ratios imply more negative lymph nodes in relation to positive lymph nodes, which was significantly associated with survival. We believe that the proposed nR is a friendlier to use format because of its intuitive interpretation.
Literatur
1.
Zurück zum Zitat Shi R, Chen Q, Ding JB, Yang Z, Pan G, Jiang D et al (2016) Increased number of negative lymph nodes is associated with improved survival outcome in node positive gastric cancer following radical gastrectomy. Oncotarget 7(23):35084–35091CrossRef Shi R, Chen Q, Ding JB, Yang Z, Pan G, Jiang D et al (2016) Increased number of negative lymph nodes is associated with improved survival outcome in node positive gastric cancer following radical gastrectomy. Oncotarget 7(23):35084–35091CrossRef
2.
Zurück zum Zitat Zheng W, Ji T, Lin Y, Li R (2016) The prognostic value of lymph nodes count on survival of patients with node-negative gastric cancer. Oncotarget 7(28):43680–43688CrossRef Zheng W, Ji T, Lin Y, Li R (2016) The prognostic value of lymph nodes count on survival of patients with node-negative gastric cancer. Oncotarget 7(28):43680–43688CrossRef
3.
Zurück zum Zitat Ji X, Bu Z-D, Li Z-Y, Wu A-W, Zhang L-H, Zhang J et al (2017) Prognostic significance of the total number of harvested lymph nodes for lymph node-negative gastric cancer patients. BMC Cancer 17(1):558CrossRef Ji X, Bu Z-D, Li Z-Y, Wu A-W, Zhang L-H, Zhang J et al (2017) Prognostic significance of the total number of harvested lymph nodes for lymph node-negative gastric cancer patients. BMC Cancer 17(1):558CrossRef
4.
Zurück zum Zitat Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513(7517):202–209CrossRef Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513(7517):202–209CrossRef
5.
Zurück zum Zitat Martinez VD, Enfield KS, Rowbotham DA, Lam WL (2016) An atlas of gastric PIWI-Interacting RNA transcriptomes and their utility for identifying signatures of gastric cancer recurrence. Gastric Cancer 19(2):660–665CrossRef Martinez VD, Enfield KS, Rowbotham DA, Lam WL (2016) An atlas of gastric PIWI-Interacting RNA transcriptomes and their utility for identifying signatures of gastric cancer recurrence. Gastric Cancer 19(2):660–665CrossRef
6.
Zurück zum Zitat Kanda M, Kodera Y (2015) Recent advances in the molecular diagnostics of gastric cancer. World J Gastroenterol 21(34):9838–9852CrossRef Kanda M, Kodera Y (2015) Recent advances in the molecular diagnostics of gastric cancer. World J Gastroenterol 21(34):9838–9852CrossRef
7.
Zurück zum Zitat Marrelli D, Polom K, Neri A, Roviello F (2018) Clinical impact of molecular classifications in gastric cancer. Updates Surg 70(2):225–232CrossRef Marrelli D, Polom K, Neri A, Roviello F (2018) Clinical impact of molecular classifications in gastric cancer. Updates Surg 70(2):225–232CrossRef
10.
Zurück zum Zitat Song Y, Wang J, Cheng Z, Gao P, Sun J, Chen X et al (2017) Quantitative global proteome and lysine succinylome analyses provide insights into metabolic regulation and lymph node metastasis in gastric cancer. Scientific Reports [Internet]. https://www.nature.com/articles/srep42053Accessed 14 May 2019 Song Y, Wang J, Cheng Z, Gao P, Sun J, Chen X et al (2017) Quantitative global proteome and lysine succinylome analyses provide insights into metabolic regulation and lymph node metastasis in gastric cancer. Scientific Reports [Internet]. https://​www.​nature.​com/​articles/​srep42053Accessed 14 May 2019
11.
Zurück zum Zitat Philippron A, Bollschweiler E, Kunikata A, Plum P, Schmidt C, Favi F et al (2016) Prognostic relevance of lymph node regression after neoadjuvant chemoradiation for esophageal cancer. Semin Thorac Cardiovasc Surg 28(2):549–558CrossRef Philippron A, Bollschweiler E, Kunikata A, Plum P, Schmidt C, Favi F et al (2016) Prognostic relevance of lymph node regression after neoadjuvant chemoradiation for esophageal cancer. Semin Thorac Cardiovasc Surg 28(2):549–558CrossRef
12.
Zurück zum Zitat Becker K, Langer R, Reim D, Novotny A, Meyer zum Buschenfelde C, Engel J et al (2011) Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases. Ann Surg 253(5):934–939CrossRef Becker K, Langer R, Reim D, Novotny A, Meyer zum Buschenfelde C, Engel J et al (2011) Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases. Ann Surg 253(5):934–939CrossRef
13.
Zurück zum Zitat Davies AR, Myoteri D, Zylstra J, Baker CR, Wulaningsih W, Van Hemelrijck M et al (2018) Lymph node regression and survival following neoadjuvant chemotherapy in oesophageal adenocarcinoma: lymph node regression in oesophageal cancer. Br J Surg 105(12):1639–1649CrossRef Davies AR, Myoteri D, Zylstra J, Baker CR, Wulaningsih W, Van Hemelrijck M et al (2018) Lymph node regression and survival following neoadjuvant chemotherapy in oesophageal adenocarcinoma: lymph node regression in oesophageal cancer. Br J Surg 105(12):1639–1649CrossRef
14.
Zurück zum Zitat Zhu Y-L, Sun Y-K, Xue X-M, Yue J-Y, Yang L, Xue L-Y (2019) Unnecessity of lymph node regression evaluation for predicting gastric adenocarcinoma outcome after neoadjuvant chemotherapy. World J Gastrointest Oncol 11(1):48–58CrossRef Zhu Y-L, Sun Y-K, Xue X-M, Yue J-Y, Yang L, Xue L-Y (2019) Unnecessity of lymph node regression evaluation for predicting gastric adenocarcinoma outcome after neoadjuvant chemotherapy. World J Gastrointest Oncol 11(1):48–58CrossRef
15.
Zurück zum Zitat Marchet A, Mocellin S, Ambrosi A, de Manzoni G, Leo AD, Marrelli D et al (2008) The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol 34(2):159–165CrossRef Marchet A, Mocellin S, Ambrosi A, de Manzoni G, Leo AD, Marrelli D et al (2008) The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol 34(2):159–165CrossRef
16.
Zurück zum Zitat Xiao L-B, Yu J-X, Wu W-H, Xu F-F, Yang S-B (2011) Superiority of metastatic lymph node ratio to the 7th edition UICC N staging in gastric cancer. World J Gastroenterol 17(46):5123–5130CrossRef Xiao L-B, Yu J-X, Wu W-H, Xu F-F, Yang S-B (2011) Superiority of metastatic lymph node ratio to the 7th edition UICC N staging in gastric cancer. World J Gastroenterol 17(46):5123–5130CrossRef
17.
Zurück zum Zitat Wang J, Dang P, Raut CP, Pandalai PK, Maduekwe UN, Rattner DW et al (2012) Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Ann Surg 255(3):478–485CrossRef Wang J, Dang P, Raut CP, Pandalai PK, Maduekwe UN, Rattner DW et al (2012) Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Ann Surg 255(3):478–485CrossRef
18.
Zurück zum Zitat Wu X-J, Miao R-L, Li Z-Y, Bu Z-D, Zhang L-H, Wu A-W et al (2015) Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer. Eur J Surg Oncol 41(7):927–933CrossRef Wu X-J, Miao R-L, Li Z-Y, Bu Z-D, Zhang L-H, Wu A-W et al (2015) Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer. Eur J Surg Oncol 41(7):927–933CrossRef
19.
Zurück zum Zitat Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJH, Nicolson M et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355(1):11–20CrossRef Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJH, Nicolson M et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355(1):11–20CrossRef
20.
Zurück zum Zitat Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345(10):725–730CrossRef Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345(10):725–730CrossRef
21.
Zurück zum Zitat Manzoni GD, Marrelli D, Baiocchi GL, Morgagni P, Saragoni L, Degiuli M et al (2017) The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015. Gastric Cancer 20(1):20–30CrossRef Manzoni GD, Marrelli D, Baiocchi GL, Morgagni P, Saragoni L, Degiuli M et al (2017) The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015. Gastric Cancer 20(1):20–30CrossRef
22.
Zurück zum Zitat Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D et al (2016) Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 27(suppl 5):v38–49CrossRef Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D et al (2016) Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 27(suppl 5):v38–49CrossRef
23.
Zurück zum Zitat Siewert JR, Böttcher K, Stein HJ, Roder JD (1998) Relevant prognostic factors in gastric cancer: 10-year results of the German Gastric Cancer Study. Ann Surg 228(4):449–461CrossRef Siewert JR, Böttcher K, Stein HJ, Roder JD (1998) Relevant prognostic factors in gastric cancer: 10-year results of the German Gastric Cancer Study. Ann Surg 228(4):449–461CrossRef
26.
Zurück zum Zitat Chen S, Zhao B-W, Li Y-F, Feng X-Y, Sun X-W, Li W et al (2012) The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1101 patients. PLoS One 7(11):e49424CrossRef Chen S, Zhao B-W, Li Y-F, Feng X-Y, Sun X-W, Li W et al (2012) The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1101 patients. PLoS One 7(11):e49424CrossRef
27.
Zurück zum Zitat Kutlu OC, Watchell M, Dissanaike S (2015) Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients. Surg Oncol 24(2):84–88CrossRef Kutlu OC, Watchell M, Dissanaike S (2015) Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients. Surg Oncol 24(2):84–88CrossRef
28.
Zurück zum Zitat Bouliaris K, Rachiotis G, Diamantis A, Christodoulidis G, Polychronopoulou E, Tepetes K (2017) Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system. Eu J Surg Oncol (EJSO) 43(7):1350–1356CrossRef Bouliaris K, Rachiotis G, Diamantis A, Christodoulidis G, Polychronopoulou E, Tepetes K (2017) Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system. Eu J Surg Oncol (EJSO) 43(7):1350–1356CrossRef
29.
Zurück zum Zitat Junior C, Da WL, Coimbra FJF, Batista TP, de Ribeiro HSC, Diniz AL et al (2013) Evaluation of N-ratio in selecting patients for adjuvant chemoradiotherapy after D2-gastrectomy. Arq Gastroenterol 50(4):257–263CrossRef Junior C, Da WL, Coimbra FJF, Batista TP, de Ribeiro HSC, Diniz AL et al (2013) Evaluation of N-ratio in selecting patients for adjuvant chemoradiotherapy after D2-gastrectomy. Arq Gastroenterol 50(4):257–263CrossRef
30.
Zurück zum Zitat Baiocchi GL, Tiberio GA, Minicozzi AM, Morgagni P, Marrelli D, Bruno L et al (2010) A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg 252(1):70–73CrossRef Baiocchi GL, Tiberio GA, Minicozzi AM, Morgagni P, Marrelli D, Bruno L et al (2010) A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg 252(1):70–73CrossRef
31.
Zurück zum Zitat Xu D, Huang Y, Geng Q, Guan Y, Li Y, Wang W et al (2012) Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system. PLoS One 7(6):e38681CrossRef Xu D, Huang Y, Geng Q, Guan Y, Li Y, Wang W et al (2012) Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system. PLoS One 7(6):e38681CrossRef
34.
Zurück zum Zitat Feinstein AR, Sosin DM, Wells CK (1985) The will rogers phenomenon. N Engl J Med 312(25):1604–1608CrossRef Feinstein AR, Sosin DM, Wells CK (1985) The will rogers phenomenon. N Engl J Med 312(25):1604–1608CrossRef
35.
Zurück zum Zitat European Chapter of International Gastric Cancer Association, Mariette C, Carneiro F, Grabsch HI, van der Post RS, Allum W et al (2019) Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma. Gastric Cancer 22(1):1–9CrossRef European Chapter of International Gastric Cancer Association, Mariette C, Carneiro F, Grabsch HI, van der Post RS, Allum W et al (2019) Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma. Gastric Cancer 22(1):1–9CrossRef
36.
Zurück zum Zitat Gullo I, Carneiro F, Oliveira C, Almeida GM (2018) Heterogeneity in gastric cancer: from pure morphology to molecular classifications. Pathobiology 85(1–2):50–63CrossRef Gullo I, Carneiro F, Oliveira C, Almeida GM (2018) Heterogeneity in gastric cancer: from pure morphology to molecular classifications. Pathobiology 85(1–2):50–63CrossRef
Metadaten
Titel
The impact of negative lymph nodes in the survival outcomes of pN+ patients following radical gastrectomy: the inverse lymph node ratio as a better score to study negative lymph nodes
verfasst von
Paulo Matos da Costa
Patrícia Lages
Susana Onofre
Ruy M. Ribeiro
Publikationsdatum
09.05.2020
Verlag
Springer International Publishing
Erschienen in
Updates in Surgery / Ausgabe 4/2020
Print ISSN: 2038-131X
Elektronische ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-020-00757-y

Weitere Artikel der Ausgabe 4/2020

Updates in Surgery 4/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.